CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Restricted Stock Units 10b5-1 | −550 | 1,650 | ||
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +13,575 | 13,575 | ||
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Grant or award · Restricted Stock Units 10b5-1 | +5,442 | 5,442 | ||
| 2026-02-27 | JANNEY DANIEL Director | Sale 10b5-1 | −9,430 | $275.45 | $2.6M | 75,666 |
| 2026-02-27 | JANNEY DANIEL Director | Sale 10b5-1 | −2,373 | $276.17 | $655K | 73,293 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise | +22,500 | 1,436,211 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Shares withheld for taxes | −10,236 | $275.64 | $2.8M | 1,425,975 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise | +4,000 | 1,429,975 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Shares withheld for taxes | −1,820 | $275.64 | $502K | 1,428,155 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise | +8,750 | 1,486,806 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Shares withheld for taxes | −3,981 | $275.64 | $1.1M | 1,482,825 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise | +26,250 | 1,509,075 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Shares withheld for taxes | −11,942 | $275.64 | $3.3M | 1,497,133 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise | +5,725 | 1,502,858 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Shares withheld for taxes | −2,605 | $275.64 | $718K | 1,500,253 |
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise · Performance Stock Units | −22,500 | 0 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Option exercise · Restricted Stock Units | −4,000 | 12,000 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Grant or award · Stock Option (Right to Buy) | +18,100 | 18,100 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Grant or award · Restricted Stock Units | +7,256 | 7,256 | ||
| 2026-02-27 | Krishnan Suma President, R&D | Grant or award · Performance Stock Units | +43,536 | 43,536 |
Page 6 of 35 · 689 trades